Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies
Originally published on LinkedIn on February 3, 2026
As Walt Disney put it, “We keep moving forward, opening new doors and doing new things, because we’re curious and curiosity keeps leading us down new paths.” This third and final piece in the mini‑series is my attempt to open one more door—not with another long article, but with a short story brought to life on screen, and told in under 5 minutes.
You’ll see what challenges exist now, and how patients, health systems, community sites, CROs, retail‑based specialty pharmacies, industry partners, and others could all become part of a more connected, scalable, human experience. Some of these ideas are already in motion. Others are just on the edge—entirely possible if we decide to build them.
Disney once said, “You can dream, create, design and build the most wonderful place in the world, but it requires people to make the dream a reality.” Parts 1 and 2 were about naming the problem and sketching a different blueprint. This last chapter of the series is an invitation: to see that future, to feel it, and then to decide whether we’re willing to be the people who make it real.
I hope this little film with Tuffy (the lovable immune cell) sparks a bit of imagination—and maybe a few good conversations about how we move from the current state to the future one together.
For another way to view this future, the following table shows current and a possible future state
YouTube content: Story by Adrienne B. Mendoza, MHA, with animation support from Kling.ai. Copyright (2026) BBG Advanced Therapies, a subsidiary of BioBridge Global. All rights reserved.
About Tuffy: Tuffy is a differentiated immune cell committed to improving access to advanced cell and gene therapies. The stories are educational and for general information only, are not medical advice, and are not a substitute for care from a qualified health professional. They reflect my personal and professional perspectives. You may spot subtle nods to BioBridge Global and BBG Advanced Therapies, where I work, but Tuffy was created to fulfill a role to be a neutral, plain‑language guide that biotech professionals, community leaders, healthcare and patient advocates can share.
